8 research outputs found

    New York\u27s Delivery System Reform Incentive Payment (DSRIP) Program: How DSRIPtive will this $8 Billion Initiative Be?

    Get PDF
    For over 30 years, James B. Couch, M.D., J.D., FACPE, has been a practicing physician, attorney and senior executive for leading health care, financial, legal and professional services organizations. He has devoted his career to quality and patient safety, especially where the practices and principles of medicine, law, information technology, business and risk management merge. Dr. Couch’s Forum presentation will address what the NY Delivery System Reform Incentive Payment (DSRIP) program is and why it is important to healthcare transformation. He will discuss how the key principles and projects of the NY DSRIP program may combine to promote achievement of the Quadruple Aim. Lastly, Dr. Couch will describe how NY DSRIP’s performance-based funds flow to Performing Provider Systems (PPS) and impact health systems. Dr. Couch has worked extensively in evaluating and positioning leading edge cloud-based electronic health information systems, clinical and population health analytics products for use by top healthcare providers and payers. Couch has published on the development of accountable care capable organizations, and the use of disease and population health management methodologies and health IT to continuously improve patient safety and healthcare quality. Presentation: 54 minutes PowerPoint slides at bottom of pag

    Healthcare Analytics Leadership: Clinical & Business Intelligence Plan Development

    Get PDF
    Future healthcare leaders require expert knowledge and practical capabilities in the evaluation, selection, application and ongoing oversight of the best types of analytics to create continuous learning healthcare systems. These systems may result in continuously improving the demonstrable quality, safety and efficiency of healthcare organizations. Data is an asset for organizations. However, many companies do not know how to establish analytical road maps for future action. Population Health Intelligence describes a new discipline whose role is to collect, organize, harmonize, analyze, disseminate and act upon the data available to clinicians, health system leaders, the pharmaceutical and biotechnology industry, and healthcare payers. This webinar on Analytics Leadership will demonstrate how to create and implement Clinical & Business Intelligence Plans that transform data into actionable organizational insights. Agenda Introduction Healthcare Analytics Leadership: Clinical & Business Intelligence Plan Development Population Health Intelligence Presentation: 53:3

    Estimation of the Mortalities of the Immature Stages and Adults

    No full text

    Diseases and Mortalities of Fishes and Other Animals In the Gulf of Mexico

    No full text
    Most mortality results from natural causes including red tide which is primarily restricted to West Florida and cold-kills that have greater influence in the warmer regions of South Texas and South Florida, but also kill a significant amount of fish and other animals in the northern Gulf. With the exception of red tide and other harmful algal blooms, the health of the Gulf has not been systematically studied. Mexico has only recently started to evaluate the health of its coastlines. Mortalities of marine animals, particularly fishes, in the Gulf caused by natural and anthropogenic events seem to interact with infectious disease agents and noninfectious diseases, but the mortalities are often attributed to the disease agents alone. “Events” that cause mortalities include eutrophication; hypoxia; algal blooms; temperature, salinity, and weather extremes; and chemical and sediment pollution. “Diseases” include those caused by infectious agents, parasites, neoplasms, and developmental abnormalities. Interactions of the effects of diseases and stressful events are considered important but little investigated

    Plötzlicher Tod im Erwachsenenalter

    No full text

    3 Systematics of the Straminipila: Labyrinthulomycota, Hyphochytriomycota, and Oomycota

    No full text

    Management of the Hypertensive Child

    No full text

    Epidemiology of Hypertension in Children

    No full text
    corecore